Agencies | Governor
Virginia Regulatory Town Hall
Department of Health Professions
Board of Optometry
Regulations of the Virginia Board of Optometry [18 VAC 105 ‑ 20]
This action is exempt from the executive branch review process.
Addition of gabapentin to TPA formulary
General Information
Action Summary House bill 2557 placed the drug gabapentin as a controlled substance in Schedule V. Regulations of the Board of Optometry currently prohibit optometrists from prescribing Schedule V drugs. Since July 1, 2019, optometrists have not been able to prescribe gabapentin; therefore, the only alternative they now have for pain control for certain patients is prescribing of an opioid. To remediate the problem, the Board is amending 18VAC105-20-47 to add gabapentin to the TPA formulary. There is also a correction to that section to reflect that there is an exception allowed in A 1 for prescribing hydrocodone in combination with acetaminophen. Subsections A and B are currently inconsistent.
Chapters Affected Only affects this chapter.
Exempt from APA Yes, this action is exempt from Article 2 of the Administrative Process Act.
Exempt Citation: 2.2-4002(14)
RIS Project Yes  [006134]
New Periodic Review This action will not be used to conduct a new periodic review.
Stages associated with this regulatory action.
Stage ID Stage Type Status
8745 Proposed Stage complete. Comment period ended 10/30/2019.
8818 Final Stage complete. This regulation became effective on 01/22/2020.
Contact Information
Name / Title: Leslie L. Knachel  / Executive Director
Address: 9960 Mayland Drive
Suite 300
Richmond, VA 23233
Email Address:
Phone: (804)597-4130    FAX: (804)527-4471    TDD: ()-

This person is the primary contact for this board.